246 related articles for article (PubMed ID: 31215423)
1. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
[TBL] [Abstract][Full Text] [Related]
2. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
3. Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions.
Wu KA; Wu CC; Chen CD; Chu CM; Shih LJ; Liu YC; Wang CL; Lin HH; Yang CY
Sci Rep; 2017 Jun; 7(1):4026. PubMed ID: 28642494
[TBL] [Abstract][Full Text] [Related]
4. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.
Yang CY; Kuo YH; Chen M; Wang CL; Shih LJ; Liu YC; Hsueh PC; Lai YH; Chu CM; Wu CC; Wu KA
Sci Rep; 2021 Jan; 11(1):1763. PubMed ID: 33469074
[TBL] [Abstract][Full Text] [Related]
5. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
7. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Pleural Fluid Lactate for Diagnosis and Management of Parapneumonic Pleural Effusion.
Santotoribio JD; Alnayef-Hamwie H; Batalha-Caetano P; Perez-Ramos S; Pino MJ
Clin Lab; 2016 Sep; 62(9):1683-1687. PubMed ID: 28164581
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
10. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.
Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM
Lung; 2014 Aug; 192(4):577-81. PubMed ID: 24913743
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.
Kho SS; Chan SK; Yong MC; Cheah HM; Lee YG; Tie ST
Respir Investig; 2020 Sep; 58(5):367-375. PubMed ID: 32107195
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.
Saraya T; Ohkuma K; Watanabe T; Mikura S; Kobayashi F; Aso J; Nunokawa H; Honda K; Ogawa Y; Tamura M; Sada M; Oda M; Inoue M; Yokoyama T; Kurai D; Ishii H; Kimura H; Takizawa H
Lung; 2018 Apr; 196(2):249-254. PubMed ID: 29353318
[TBL] [Abstract][Full Text] [Related]
15. A novel biomarker for pleural effusion diagnosis: Interleukin-36γ in pleural fluid.
Guo L; Zhang Q; Lv C; Ma X; Song X; Huang J; Chen W; Li C; Ding Q
J Clin Lab Anal; 2023 Jan; 37(1):e24799. PubMed ID: 36478612
[TBL] [Abstract][Full Text] [Related]
16. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury.
Seibert FS; Pagonas N; Arndt R; Heller F; Dragun D; Persson P; Schmidt-Ott K; Zidek W; Westhoff TH
Acta Physiol (Oxf); 2013 Apr; 207(4):700-8. PubMed ID: 23336369
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Oikonomidi S; Kostikas K; Kalomenidis I; Tsilioni I; Daenas C; Gourgoulianis KI; Kiropoulos TS
Respiration; 2010; 80(4):285-91. PubMed ID: 20453486
[TBL] [Abstract][Full Text] [Related]
18. Calprotectin and Neutrophil Gelatinase-Associated Lipocalin As Biomarkers of Acute Kidney Injury in Acute Coronary Syndrome.
Zhen XW; Song NP; Ma LH; Ma LN; Guo L; Yang XD
Am J Med Sci; 2021 Jun; 361(6):736-743. PubMed ID: 33892917
[TBL] [Abstract][Full Text] [Related]
19. A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalin.
Gümüs A; Ozkaya S; Ozyurt S; Cınarka H; Kirbas A; Sahin U; Ece F
Multidiscip Respir Med; 2014; 9(1):49. PubMed ID: 25243068
[TBL] [Abstract][Full Text] [Related]
20. Elevated pleural fluid levels of defensins in patients with empyema.
Ashitani J; Mukae H; Nakazato M; Taniguchi H; Ogawa K; Kohno S; Matsukura S
Chest; 1998 Mar; 113(3):788-94. PubMed ID: 9515858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
